Article Information
History
- July 27, 2021.
Article Versions
- Version 1 (October 23, 2020 - 05:12).
- Version 2 (October 28, 2020 - 15:12).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Matthew C. Woodruff1,2,
- Richard P. Ramonell3,
- Ankur Singh Saini1,2,
- Natalie S. Haddad4,
- Fabliha A. Anam1,2,
- Mark E. Rudolph5,
- Regina Bugrovsky1,2,
- Jennifer Hom1,2,
- Kevin S. Cashman1,2,
- Doan C. Nguyen3,
- Shuya Kyu3,
- Michael Piazza6,
- Christopher M. Tipton1,2,
- Scott A. Jenks1,2,
- F. Eun-Hyung Lee*,3 and
- Ignacio Sanz*,1,2
- 1Department of Medicine, Division of Rheumatology, Lowance Center for Human Immunology, Emory University, Atlanta, GA, USA
- 2Emory Autoimmunity Center of Excellence, Emory University, Atlanta, GA, USA
- 3Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University, Atlanta, GA, USA
- 4MicroB-plex, Atlanta, GA, USA
- 5Exagen Inc., Vista, CA, USA
- 6Nicoya, Kitchener-Waterloo, Canada
- ↵*Corresponding Authors F. Eun-Hyung Lee – F.E.Lee{at}emory.edu, Ignacio Sanz – Ignacio.sanz{at}emory.edu
These authors contributed equally to this work: Matthew C. Woodruff and Richard P. Ramonell
Posted July 27, 2021.
Relaxed peripheral tolerance drives broad de novo autoreactivity in severe COVID-19
